# Amyloidosis TTR Flow Reserve Evaluation

> **NCT05103943** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Centre Hospitalier Régional d'Orléans** · enrollment: 50 (estimated)

## Conditions studied

- Amyloid Cardiomyopathy

## Interventions

- **OTHER:** SPECT MPI

## Key facts

- **NCT ID:** NCT05103943
- **Lead sponsor:** Centre Hospitalier Régional d'Orléans
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-02-24
- **Primary completion:** 2026-12-11
- **Final completion:** 2026-12-11
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2025-12-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05103943

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05103943, "Amyloidosis TTR Flow Reserve Evaluation". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT05103943. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*